Percutaneous Coronary Intervention (PCI) Followed by Intravascular Brachytherapy (IVBT) for Management of Stent-in-Stent Restenosis (SISR) in Patients with High-Risk Coronary Artery Disease.

MLA

Matani, H., et al. “Percutaneous Coronary Intervention (PCI) Followed by Intravascular Brachytherapy (IVBT) for Management of Stent-in-Stent Restenosis (SISR) in Patients with High-Risk Coronary Artery Disease.” International Journal of Radiation Oncology, Biology, Physics, vol. 114, no. 3, Nov. 2022, p. e419. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2022.07.1610.

APA

Matani, H., Reddy, S., Renz, P. B., Wing, J., Beriwal, S., Lasorda, D., & Trombetta, M. (2022). Percutaneous Coronary Intervention (PCI) Followed by Intravascular Brachytherapy (IVBT) for Management of Stent-in-Stent Restenosis (SISR) in Patients with High-Risk Coronary Artery Disease. International Journal of Radiation Oncology, Biology, Physics, 114(3), e419. https://doi.org/10.1016/j.ijrobp.2022.07.1610

Chicago

Matani, H., S. Reddy, P.B. Renz, J. Wing, S. Beriwal, D. Lasorda, and M. Trombetta. 2022. “Percutaneous Coronary Intervention (PCI) Followed by Intravascular Brachytherapy (IVBT) for Management of Stent-in-Stent Restenosis (SISR) in Patients with High-Risk Coronary Artery Disease.” International Journal of Radiation Oncology, Biology, Physics 114 (3): e419. doi:10.1016/j.ijrobp.2022.07.1610.